The market for in-vitro diagnostics in India is made up of a number of distinct producers that are experts in the creation and manufacturing of diagnostic goods for a variety of different markets. the report titled “india in-vitro diagnostics industry analysis till 2018 – accreditation and automation to drive future growth” provides a comprehensive analysis of the various aspects such as market size of the india in-vitro diagnostics market, india immunochemistry market, india biochemistry market, india hematology market, india microbiology market, india blood gas and electrolyte market, india molecular diagnostics market, india urinalysis market and india coagulation market. In addition to this, the study discusses the market shares of significant companies in the immunochemistry, biochemistry, and microbiology sectors, as well as the total market for in-vitro diagnostics in India. India’s in-vitro diagnostics market, which has been enormously driven by the growing number of lifestyle diseases, the trend toward preventive healthcare practices, the rising disposable incomes, the initiatives of the government, and the improvement of healthcare infrastructure, recorded revenues of USD million in fiscal year 2013. When compared to the fiscal year 2012, when the total sales were USD million, the revenues climbed by 25.8 percent due to the introduction of new types of diagnostic tests that included the most recent technology. There are a variety of factors that influence the in-vitro diagnostics market in India. These factors include people who suffer from diabetes, heart, kidney, and other infectious and lifestyle diseases, as well as the overall disposable incomes in the country. These factors play a significant role in determining the revenues that are generated from the various diagnostic segments. In terms of revenue, immunochemistry was the category that contributed the most, with sales amounting to US Dollars million for the fiscal year 2013. Additionally, biochemistry, hematology, and microbiology all provided a substantial portion to the total revenues. From a value of US$ 303.2 million in fiscal year 2007 to US$ ~ million in fiscal year 2013, the in-vitro diagnostics industry in India has shown a compound annual growth rate of 19.4 percent. The market for in-vitro diagnostics in India is made up of a number of distinct producers that are experts in the creation and manufacturing of diagnostic goods for a variety of different markets. The market in India is driven not only by the presence of significant diagnostic firms in the organized sector, but also by the revenues of a large number of manufacturers operating in the unorganized section of the market. During the 2013 fiscal year, Roche was the market leader in the immunochemistry and biochemistry categories, in addition to being the market leader in the total IVD market in India. Not only is the market pushed by the presence of a number of competitors in the organized sector, but it is also driven by the importation of a great number of diagnostic goods from China and other countries. Over the course of the more recent few years, the in-vitro diagnostics market in India has shown a number of developing trends. The introduction of decentralized testing, the growing prevalence of automation in labs, the growing demand for early illness diagnosis, and the rising consolidation of laboratories are some of the most significant developments that have emerged in recent years. Quite a few pathology laboratories have made significant investments and have begun using completely automated systems for the diagnosis of infections and disorders. As a consequence of this, the accuracy of the test findings has improved, while the turnaround times have greatly decreased. An further factor that has contributed to the expansion of the market for point-of-care testing in India is the proliferation of portable diagnostics equipment. The in-vitro diagnostics industry in India is one that is undergoing rapid transformation at the moment. As a result of technological advancements, the demand for diagnostic tests from an ever-expanding population of disease-ridden individuals and individuals suffering from lifestyle diseases, as well as the transition of diagnostic product manufacturers from the unorganized segment to the organized segment, the market has been undergoing significant transformations. The in-vitro diagnostics market in India is anticipated to develop at a compound annual growth rate (CAGR) of percent from fiscal year 2013 to fiscal year 2018, resulting in it reaching a revenue of million US dollars in fiscal year 2018. You can get further information by clicking on the following link: http://www.kenresearch.com/healthcare/trial-diagnostic-services/india-in-vitro-diagnostics-market-research-report/412-91.html Ankur Gupta is the one to contact us. designation: director of marketing and communication email address: ankur@kenresearch.com phone number: 01147017199 toll-free number: +91 9015378249 description:
Author
jackemails@gmail.com